Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Anxiety Disorders 2 Weight Loss 1 Recurrence 1 Lung Neoplasms 1 Glioma 1 Fatigue 1 Depression 1 Colorectal Adenocarcinoma 1 Carcinoma, Non-Small-Cell Lung 1 Cachexia 1 Brain Neoplasms 1 Advanced Cancer 1 Adenocarcinoma of Lung 1

Interventions

Exercise 10 Diet 6 Caloric Restriction 5 Nutrition Assessment 4 Metformin 4 Octreotide 3 Megestrol Acetate 3 Cognitive Behavioral Therapy 3 anamorelin 2 Standard of Care 2 Olanzapine 2 Mirtazapine 2 Melatonin 2 Liraglutide 2 Eicosapentaenoic Acid 2 Diet, Carbohydrate-Restricted 2 Diet Therapy 2 sibutramine 1 remune 1 olanzapine-fluoxetine combination 1 lime 1 irinotecan sucrosofate 1 bermekimab 1 Weight Reduction Programs 1 Urine Specimen Collection 1 Tirzepatide 1 TOPS 1 Surveys and Questionnaires 1 Sugars 1 Sampling Studies 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Weight Loss × Fluoxetine × Clear all

NCT00489593 2015-01-08

Olanzapine in Patients With Advanced Cancer and Weight Loss

M.D. Anderson Cancer Center

Phase 1 Completed

Cachexia, Weight Loss

Data powered by HemOnc (CC BY 4.0) Colophon ⚡